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IB-IVUS derived tissue components (calcification, dense fibrosis, fibrosis, lipid pool) and
fibrous cap thickness were investigated.
Results: The percent changes in fibrous cap thickness correlated negatively and
significantly with the percent changes in external elastic membrane cross sectional area
(r-0.5, P0.0001). The %changes in fibrous cap thickness correlated negatively and
significantly with %changes in lipid pool area (r-0.61, P0.0001). The %changes in
fibrous cap thickness correlated positively with calcification, dense fibrosis or fibrosis, as
well (r0.44, P0.0001, r0.60, P0.0001, and r0.54, P0.0001, respectively).
Conclusions: Arterial remodeling with changes in lipid pool component is related to
changes in fibrous cap thickness. Positive arterial remodeling with lipid accumulation may
represent an unstable or vulnerable process of the coronary arterial plaque.
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Background: Statin theraphy have been shown the regression of coronary artery plaque.
However a few data was reported about the change of left main coronary artery.
Methods: We used Virtual Histology Intravascular Ultrasound (VH-IVUS) to assess
mild to moderate left main coronary artery (LMCA) disease in 500 consecutive pts and
identified 50 pts with who had serial VH-IVUS examinations at baseline and at follow-up
at 12 months. VH-TCFA (thin-capped fibroatheroma) was defined as necrotic core (NC)
10% of plaque area with a plaque burden of 40% and NC in contact with the lumen
for 3 image slices. Positive remodeling was a remodeling index (lesion/reference EEM
[external elastic membrane] area) 1.05.
Results: Pt age was 5713 yrs and 20% were diabetics. The incidence of LM-TCFA was
11.2% (56/500). following 16 pts with VH-TCFA at baseline and serial VH-IVUS, distal
reference lumen area was 14.64.2 mm2. LMCA length was 6.44.0mm, and the rate of
positive remodeling was 14% (8/56). 74% of VH-TCFA were located in mid-body of the
LMCA and the rest at the distal bifurcation. After 12 months of statin therapy, minimal
lumen area (12.83.8 to 12.44.5 mm2, p0.6) and maximum %NC (28.013.2 to
27.212.1, p0.8) were similar; and only 37.5% (6/16) of VH-TCFA had healed to a
non-VH-TCFA phenotype and 3 new VH-TCFA appeared (Table) even though low
density lipoprotein (LDL) level was decreased in 87.5 % (14/16) pts with 12/16 having an
LDL 100mg/dL.
Conclusions: Healing of VH-TCFA in the LMCA is not high during “routine” statin
therapy. This suggests the need for more strict control of risk factors in these pts.
Follow-up
Baseline
PIT
(n14)
ThCFA
(n5)
TCFA
(n13)
Fibrotic
(n12)
Fibrocalcific
(n6)
PIT (n14) 14
ThCFA (n1) 1
TCFA (n16) 1 10 3 2
Fibrotic (n15) 3 3 9
Fibrocalcific (n4) 4
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Background: Thin capped fibroatheroma(TCFA) is a principal pathophysiologic mech-
anism to occur acute coronary syndrome. However, the characteristics of each TCFA have
not been evaluated.
Methods: We used virtual histology-intravascular ultrasound (VH-IVUS) to assess
culprit lesions in 196 consecutive pts with ST elevation acute myocardial infarction
(STEMI) and compared culprit lesions in the RCA (59 pts) with culprit lesions in the left
coronary artery (LCA, 137 pts). VH-thin-capped fibroatheromas (VH-TCFAs) were
defined as necrotic core (NC) 10% of plaque area, plaque burden 40%, and NC in
contact with the lumen for 3 image slices.
Results: Plaque ruptures were seen in 85/196 of which 52 were located in the proximal
30mm of a coronary artery. Lesion length was similar; vessel size, plaque burden,
minimal lumen area, and average %NC were larger; and VH-TCFA phenotype was more
common (60% vs 31%, p0.001) in RCA vs LCA-STEMI (Table). Importantly, culprit
lesion plaque ruptures were more common in RCA (45.5%) vs LAD-STEMI (30.1%,
p0.034) as was the frequency of VH-TCFA phenotype in the setting of culprit plaque
ruptures (72% in RCA vs 29% in LAD-STEMI, p0.005).
Conclusions: Plaque ruptures are not always detected by IVUS in culprit lesions of pts
presenting with STEMI, and VH-TCFA phenotype is not always seen in these culprit
lesions whether or not plaque rupture is detected. Rather, plaque rupture and VH-TCFA
phenotype in culprit lesions of STEMI pts appear to depend on location (RCA vs LCA)
and vessel size.
RCA LCA p-value
Lesion length (mm) 20.60	/7.81 23.39	/10.29 0.200
Distal reference lumen
area (mm2)
9.06	/4.05 6.84	/3.32 0.002
Minimal lumen area
(mm2)
4.52	/2.58 3.49	/1.85 0.007
Vessel area (mm2)
(ruptured site)
21.00	/6.00 16.83	/5.09 0.004
Lumen area (mm2)
(ruptured site)
7.59	/2.81 6.05	/2.33 0.020
Plaque area (mm2)
(ruptured site)
11.31	/3.92 8.30	/3.41 0.027
Ruptured cavity (mm2) 1.18	/1.05 0.83	/0.69 0.145
Remodeling index (@
ruptured site)
1.04	/0.19 1.13	/0.29 0.193
average fibrotic plaque (%) 59.96	/10.32 58.09	/13.43 0.425
average fibrofatty plaque
(%)
10.08	/5.34 9.60	/5.57 0.606
average necrotic core (%) 20.52	/8.42 17.38	/7.73 0.020
average dense calcium (%) 8.66	/6.06 10.51	/7.01 0.118
VH-IVUS phenotype 0.02
Pathologic intimal
thickening
2 8
Thick cap fibrotheroma 0 1
VH-TCFA 22 21
Fibrotic 2 13
Fibrocalcific
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Background: Copeptin has been known to predict heart failure and cardiovascular death
in patients with acute coronary syndrome.
Methods: We collected coronary arterial blood samples from the infarct artery during
primary percutaneous coronary intervention (PCI) in 80 STEMI pts and 28 controls. We
assessed commonly used cardiac biomarkers (CK, CK-MB, troponin-I, CRP) and
additionally measured recently introduced biomarkers (Copeptin [C-terminal Provaso-
pressin] and N-terminal pro-B-type natriuretic peptide [NT-proBNP]).
Results: Pt age was 5812 yrs and 93% were males. Intravascular ultrasound (IVUS) of
the culprit lesion in 80 pts showed ruptured plaques in 36 pts. STEMI pts had a higher
Copeptin level (265.89183.10 pmol/L) vs193.6760.17 pmol/L in normal controls,
p0.005. Especially, Copeptin levels were higher in ruptured plaque compared to
non-ruptured plaques: 318.83209.34 pmol/L vs 221.99151.49 pmol/L, p0.034.
While troponin I, CK-MB, and CRP were not correlated with Copeptin, NT-proBNP was
correlated with copeptin (r0.579, p0.0003). In hospital death occurred in 7 pts with a
high Copeptin level (figure); all were due to cardiogenic shock after primary PCI.
Conclusions: Copeptin levels are associated with plaque rupture in STEMI pts and
predict mortality after primary PCI.
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